Login / Signup

Adherence trajectories of buprenorphine therapy among pregnant women in a large state Medicaid program in the United States.

Wei-Hsuan Lo-CiganicJulie M DonohueJoo Yeon KimElizabeth E KransBobby L JonesDavid KelleyAlton E JamesMarian P Jarlenski
Published in: Pharmacoepidemiology and drug safety (2018)
Six buprenorphine treatment trajectories during pregnancy were identified in this population-based Medicaid cohort, with 25% of women initiating buprenorphine late during pregnancy. Understanding trajectories of buprenorphine use and factors associated with discontinuation/nonadherence may guide integration of behavioral treatment with obstetrical/gynecological care to improve buprenorphine treatment during pregnancy.
Keyphrases
  • depressive symptoms
  • palliative care
  • adipose tissue
  • polycystic ovary syndrome
  • pregnant women
  • mesenchymal stem cells
  • affordable care act
  • bone marrow
  • skeletal muscle
  • pain management